兴齐眼药：SQ-24071滴眼液获临床试验批准通知书

Core Viewpoint - The company, Xingqi Eye Medicine, has received approval from the National Medical Products Administration for clinical trials of SQ-24071 eye drops, aimed at delaying the progression of myopia in children and adolescents [1] Company Summary - Xingqi Eye Medicine announced on January 19 that it has obtained a clinical trial approval notice for SQ-24071 eye drops from the National Medical Products Administration [1]